NCT00004700View on ClinicalTrials.gov

Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 1995

Study Completion Date

January 31, 1999

Conditions
Hyperinsulinism
Interventions
DRUG

insulin-like growth factor I

All Listed Sponsors
lead

Children's Hospital of Philadelphia

OTHER

NCT00004700 - Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism | Biotech Hunter | Biotech Hunter